Pfizer To Acquire Blood Disorder Drugmaker Global Blood Ther

Pfizer Inc. (NYSE:PFE) has reached an agreement to acquire Global Blood Therapeutics Inc (NASDAQ:GBT) in a deal with $5.4 billion.

Related Keywords

Walter Schloss , Letter To Co , Global Blood Therapeutics Inc , Pfizer , Biohaven Pharmaceutical Holding , Pfizer Inc , Cantor Fitzgerald , Arena Pharmaceuticals , Rv Capital Co , Dear Co , Global Blood Therapeutics , Wall Street Journal , Full Walter Schloss Series , Co Investor Letter , Dear Co Investors , Wall Street ,